nDDx
nSarcoid, TB, mets, meningitis, (LCH)
nClinical/Path
n3% with no systemic disease, 5% clinically, 15% at autopsy
n50% of CNS involvement is subclinical
nNoncaseating granulomas, intraaxial or extraaxial, perivascular, vasculitis/infarcts
nImaging
nMR- diffuse or focal leptomeningeal/pachymeningeal enhancement, nonspecific white matter lesions simulate MS,
focal mass, basal meningeal, pituitary/infundibulum, cranial nerve enhancement, hydrocephalus